Jianmin Pharmaceutical Group Co Ltd (600976) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.039x

Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥106.82 Million ≈ $15.63 Million USD) by net assets (CN¥2.72 Billion ≈ $398.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600976 equity to assets ratio to measure how much of total assets are equity-financed.

Jianmin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Jianmin Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Oscotec Inc KQ:039200	0.263x
President Bakery Public Company Limited BK:PB	0.029x
Hubei Century Network Technology Co Ltd SHE:300494	0.014x
Guizhou Guihang Automotive Components Co Ltd SHG:600523	-0.002x
Reitir fasteignafélag hf IC:REITIR	0.028x
Guangzhou KingTeller Technology Co Ltd SHE:002177	0.006x
Anpec Electronics TWO:6138	0.041x
Shanghai Shenda Co Ltd SHG:600626	0.042x

Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see 600976 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.72 Billion ≈ $398.20 Million	CN¥274.53 Million ≈ $40.17 Million	0.101x	+5.52%
2024-12-31	CN¥2.45 Billion ≈ $358.56 Million	CN¥234.27 Million ≈ $34.28 Million	0.096x	-19.62%
2023-12-31	CN¥2.26 Billion ≈ $330.19 Million	CN¥268.39 Million ≈ $39.27 Million	0.119x	+2.92%
2022-12-31	CN¥1.87 Billion ≈ $273.32 Million	CN¥215.87 Million ≈ $31.59 Million	0.116x	-30.07%
2021-12-31	CN¥1.57 Billion ≈ $229.48 Million	CN¥259.18 Million ≈ $37.93 Million	0.165x	+74.20%
2020-12-31	CN¥1.32 Billion ≈ $193.63 Million	CN¥125.54 Million ≈ $18.37 Million	0.095x	+53.92%
2019-12-31	CN¥1.21 Billion ≈ $176.76 Million	CN¥74.45 Million ≈ $10.89 Million	0.062x	+10.97%
2018-12-31	CN¥1.15 Billion ≈ $167.56 Million	CN¥63.60 Million ≈ $9.31 Million	0.056x	+74.75%
2017-12-31	CN¥1.11 Billion ≈ $162.05 Million	CN¥35.20 Million ≈ $5.15 Million	0.032x	-71.21%
2016-12-31	CN¥1.03 Billion ≈ $150.92 Million	CN¥113.84 Million ≈ $16.66 Million	0.110x	+127.22%
2015-12-31	CN¥997.36 Million ≈ $145.94 Million	CN¥48.45 Million ≈ $7.09 Million	0.049x	-52.85%
2014-12-31	CN¥1.00 Billion ≈ $146.63 Million	CN¥103.23 Million ≈ $15.11 Million	0.103x	+113.60%
2013-12-31	CN¥940.46 Million ≈ $137.62 Million	CN¥45.36 Million ≈ $6.64 Million	0.048x	-55.63%
2012-12-31	CN¥903.10 Million ≈ $132.15 Million	CN¥98.17 Million ≈ $14.37 Million	0.109x	+226.20%
2011-12-31	CN¥876.97 Million ≈ $128.33 Million	CN¥-75.54 Million ≈ $-11.05 Million	-0.086x	-148.72%
2010-12-31	CN¥848.81 Million ≈ $124.21 Million	CN¥150.08 Million ≈ $21.96 Million	0.177x	+117.47%
2009-12-31	CN¥820.32 Million ≈ $120.04 Million	CN¥66.69 Million ≈ $9.76 Million	0.081x	-43.79%
2008-12-31	CN¥761.24 Million ≈ $111.39 Million	CN¥110.11 Million ≈ $16.11 Million	0.145x	+1660.69%
2007-12-31	CN¥742.63 Million ≈ $108.67 Million	CN¥-6.88 Million ≈ $-1.01 Million	-0.009x	-112.65%
2006-12-31	CN¥766.61 Million ≈ $112.18 Million	CN¥56.18 Million ≈ $8.22 Million	0.073x	+260.73%
2005-12-31	CN¥759.65 Million ≈ $111.16 Million	CN¥-34.63 Million ≈ $-5.07 Million	-0.046x	-877.87%
2004-12-31	CN¥705.12 Million ≈ $103.18 Million	CN¥4.13 Million ≈ $604.74K	0.006x	-59.37%
2003-12-31	CN¥290.32 Million ≈ $42.48 Million	CN¥4.19 Million ≈ $612.80K	0.014x	--

About Jianmin Pharmaceutical Group Co Ltd

SHG:600976 China Drug Manufacturers - Specialty & Generic

Market Cap

$673.19 Million

CN¥4.60 Billion CNY

Market Cap Rank

#10745 Global

#2919 in China

Share Price

CN¥29.99

Change (1 day)

+6.88%

52-Week Range

CN¥24.91 - CN¥43.36

All Time High

CN¥83.88